Trident Lifeline (543616)
FAST GROWERScore breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹279.85 |
| Market Cap | ₹326.41 Cr |
| P/E Ratio | 16.56 |
| ROCE | 18.12% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 54.12% |
| Debt/Equity | — |
| Sales Growth | 117.33% |
| 52-Week Range | ₹229.95 — ₹328 |
| Sector | Pharmaceuticals & Biotechnology |
Trident Lifeline trades with a P/E ratio of 16.56, ROCE of 18.12%, profit growth of 54.12%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer